A big pharma brand needed a deeper understanding of the AL Amyloidosis journey from the patient perspective, mapped out by key steps and milestones. They wanted to uncover any opportunities by identifying the white space in the current market and ways to make a difference to patients’ lives.

Additionally, they wanted the results to be compared and contrasted with studies by physicians, to identify potential gaps and differences.